These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 125398)

  • 21. Evaluation of basal hormone levels in hirsute women.
    Bohnet HG; Kato K
    Exp Clin Endocrinol; 1987 Mar; 89(1):31-8. PubMed ID: 2954834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H; Rittmaster RS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgens in hirsute women referred for electroepilation.
    Fogh H; Worm AM; Forkert B; Bennett P
    Acta Derm Venereol; 1989; 69(2):179-82. PubMed ID: 2564241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral steroid levels in a patient with congenital absence of the uterus.
    Chang RJ; Abraham GE
    Obstet Gynecol; 1975 Sep; 46(3):320-22. PubMed ID: 125866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of an oral contraceptive on adrenal and ovarian androgenic steroids.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1984 Jan; 63(1):12-4. PubMed ID: 6228751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroid hormone levels in serum and skin receptor concentrations in hirsutism.
    Schmidt JB; Huber J; Spona J
    Endocrinol Exp; 1985 Sep; 19(3):147-55. PubMed ID: 2931274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women.
    Ho Yuen B; Mincey EK
    Am J Obstet Gynecol; 1983 Jan; 145(2):152-7. PubMed ID: 6401396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dexamethasone and clomiphene citrate on peripheral steroid levels and ovarian function in a hirsute amenorrheic patient.
    Chang RJ; Abraham GE
    Fertil Steril; 1976 Jun; 27(6):640-6. PubMed ID: 132375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.
    Rittmaster RS; Deshwal N; Lehman L
    J Clin Endocrinol Metab; 1993 May; 76(5):1295-300. PubMed ID: 8388405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of spironolactone on adrenal steroidogenesis in hirsute women.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Nov; 44(5):595-9. PubMed ID: 2996951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of the effects of dexamethasone administration on urinary 17-ketosteroid and serum androgen levels in patients with hirsutism.
    Judd HL; McPherson RA; Rakoff JS; Yen SS
    Am J Obstet Gynecol; 1977 Jun; 128(4):408-17. PubMed ID: 141210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of short- and long-term dexamethasone on 3 alpha-androstanediol glucuronide in hirsute women.
    Meikle AW; Odell WD
    Fertil Steril; 1986 Aug; 46(2):227-31. PubMed ID: 3015694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menstrual history as a determinant of current bone density in young hirsute women.
    Castelo-Branco C; Pons F; Martinez de Osaba MJ; Garrido J; Fortuny A
    Metabolism; 1996 Apr; 45(4):515-8. PubMed ID: 8609841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.